Harnessing Omics Approaches on Advanced Preclinical Models to Discovery Novel Therapeutic Targets for the Treatment of Metastatic Colorectal Cancer

Metastatic colorectal cancer (mCRC) remains challenging because of the emergence of resistance mechanisms to anti-epidermal growth factor receptor (EGFR) therapeutics, so more effective strategies to improve the patients’ outcome are needed. During the last decade, the application of a multi-omics a...

Descripción completa

Detalles Bibliográficos
Autores principales: Porru, Manuela, Zizza, Pasquale, Panera, Nadia, Alisi, Anna, Biroccio, Annamaria, Leonetti, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408740/
https://www.ncbi.nlm.nih.gov/pubmed/32650388
http://dx.doi.org/10.3390/cancers12071830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408740/
https://www.ncbi.nlm.nih.gov/pubmed/32650388
http://dx.doi.org/10.3390/cancers12071830

Ejemplares similares